Welcome to CESPHN

In order to tailor the site to your needs, please click the button that relates best to you.

So long as you have cookies enabled you will only need to do this once. However, you can change your selection at any time using the dropdown navigation option above the CESPHN logo, top left.

Close this window
IMPORTANT NOTICE

This post is not the latest immunisation update and therefore may contain information or advice that is out of date. Please see our most recent update here.

Immunisation weekly update – 30 November 2022

20190319 Immunisation Needle Icons 31

New recommended name for Monkeypox: ‘mpox’

On 28 November, the World Health Organization (WHO) announced it would start using a new preferred term, “mpox”, as a synonym for monkeypox and urged others to follow suit after receiving complaints that the current name for the disease was racist and stigmatising. Both names will be used simultaneously for one year while “monkeypox” is phased out.

Meningococcal disease alert

Providers are encouraged to check that patients are up to date with meningococcal vaccinations. Children under five and 15 to 25-year-olds are at the greatest risk of contracting the disease.

In NSW there have been 29 cases of meningococcal disease reported in NSW so far in 2022, and a second death due to meningococcal B disease occurred in NSW in a man in his 20s last week.

Meningococcal disease is a rare, but serious and sometimes fatal infection, and vaccination is the best way to prevent the harmful effects of meningococcal disease.

Meningococcal ACWY vaccine is provided free under the National Immunisation Program (NIP) for:

  • babies at 12 months
  • adolescents (year 10 school vaccination program)
  • people of all ages with certain medical conditions

Meningococcal B vaccine is provided free under the National Immunisation Program (NIP) for:

  • Aboriginal children up to the age of two years
  • people with certain medical conditions

However, all children from six weeks of age can have the Men B vaccine to reduce the risk of infection via private prescription. 

For more information on vaccination or symptoms, transmission, risks and treatment of Meningococcal, see the NSW Health website.

New and updated resources

COVID-19 resources – UPDATED:

Immunisation Education

COVID-19 response update

  • About: primary care update on the COVID-19 response and the vaccine rollout – key updates and Q&A
  • When: Thursday | 1 December 2022 | 12:00pm
  • Register: Registration not required – Click linkto join